TFE3 and renal cell carcinoma: (12), 10.2% (31 out of 303) of RCCs expressed positive nuclear TFE3 immunoreactivity and 19.4% (6 out of 31) of TFE3-positive RCCs did not belong to the Xp11.2 translocation RCC group.